Concepedia

L S Reynolds

LS

8

Publications

448

Citations

8

H-Index

1981

Active since

Affiliations

Pfizer (United States)(Current)

L S Reynolds is an author at Pfizer (United States) specializing in medicine, neurophysiology, and nervous system.

Top concepts

Publications per year

1981–2001

8

Publications

8

Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.

Stafford McLean, Alan H. Ganong, P A Seymour et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 222 citations

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.

Stafford McLean, Alan H. Ganong, Patricia A. Seymour et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 74 citations

Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin NK1 receptor

Stafford McLean, Alan H. Ganong, P A Seymour et al. · Regulatory Peptides · 1992 · 43 citations

, , +9

Activation of postsynaptic 5‐HT<sub>1A</sub> receptors by fluoxetine despite the loss of firing‐dependent serotonergic input: Electrophysiological and neurochemical studies

Jeffrey Sprouse, John P. Braselton, L S Reynolds et al. · Synapse · 2001 · 27 citations

, , +19

Characterization of end-plate conductance in transected frog muscle: modification by drugs.

Jeremy J. Lambert, N. N. Durant, L S Reynolds et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 26 citations

Rows per page

1–5 of 8